A Phase 1, Double-Blind (Sponsor Open), Randomized, Placebo-Controlled Trial To Evaluate The Effects Of 100 MG Once Daily Of Eplerenone On Serum Aldesterone And Plasma Renin Activity During 10 Days Of Dosing In Healthy Volunteers.
Latest Information Update: 09 Nov 2021
At a glance
- Drugs Eplerenone (Primary)
- Indications Heart failure; Hypertension
- Focus Pharmacokinetics
- Sponsors Pfizer
- 20 Oct 2009 Additional location identified as reported by ClinicalTrials.gov.
- 20 Oct 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 12 Oct 2009 New trial record